Drugmaker GSK said on Friday that the European Commission has approved Nucala (mepolizumab) as an add‑on maintenance ...

As climate change worsens respiratory diseases, doctors and drugmakers are exploring earlier diagnosis and low-carbon inhalers to cut emissions from care and protect patients. For millions of people, ...

For millions of people, climate change is already affecting their breathing, from asthma attacks caused by pollution to lung damage from wildfire smoke, and the very same health systems treating these ...

CSPC Pharmaceutical Group ( (HK:1093)) has issued an announcement. CSPC Pharmaceutical Group has received approval from China’s National Medical Products Administration to initiate clinical trials of ...

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstructive pulmonary disease.

Mohammad Allakany, GM for MEA, at ELPEN, shares how innovation, sustainability, and pharmacoeconomics are redefining what ...

House burping' is the latest thing cluttering people's feeds: short clips of people flinging open every window and door, ...

Opening windows clears germs and stale air –but timing matters. You don’t want to swap indoor pollution for outdoor exhaust.

University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the ...

Watch out for these small-caps this month. The post 2 ASX small-caps with big upside to target in February appeared first on ...

Exposure to toxic mould can have a decades-long impact on the lungs, concerning new research has revealed. Now experts reveal ...